Shao et al. [11] reported that epigenetic-related gene pathway mutations were negatively correlated with tumour recurrence (HR: 0.198; p = 0.02), while mutations in NEB, FGFR1, and SDHC were independent predictors of recurrence. Here, FGFR1 is linked to neoplasm.